KLK3 and prostate adenocarcinoma: In comparison, PSA is expressed in benign prostate tissue and in the majority of prostatic adenocarcinomas; however, it is lost in 10–20% of distant metastasis, and staining intensity decreases as compared to benign prostate tissue.